sparfloxacin has been researched along with Infections, Legionella pneumophila in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gaja, M; Saito, A | 1 |
| Dorr, MB; Edelstein, MA; Edelstein, PH; Weidenfeld, J | 1 |
2 other study(ies) available for sparfloxacin and Infections, Legionella pneumophila
| Article | Year |
|---|---|
In vitro and in vivo activities of sparfloxacin in Legionella infections.
Topics: Adult; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Erythromycin; Fluoroquinolones; Guinea Pigs; Humans; In Vitro Techniques; Legionella pneumophila; Legionnaires' Disease; Male; Microbial Sensitivity Tests; Neutrophils; Quinolones; Survival | 1995 |
In vitro activity of sparfloxacin (CI-978; AT-4140) for clinical Legionella isolates, pharmacokinetics in guinea pigs, and use to treat guinea pigs with L. pneumophila pneumonia.
Topics: Animals; Anti-Infective Agents; Antibodies, Bacterial; Body Weight; Ciprofloxacin; Erythromycin; Fluoroquinolones; Guinea Pigs; Half-Life; In Vitro Techniques; Legionella; Legionnaires' Disease; Lung; Macrophages; Male; Microbial Sensitivity Tests; Pulmonary Alveoli | 1990 |